Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pain Care Labs’ flagship products—Buzzy® for needle/injection/IV access pain and VibraCool® for musculoskeletal/post-surgical/back/neck pain—are FDA-cleared devices that use a patented combination of cold and vibration to provide noninvasive neuromodulation-based analgesia. Clinical studies have shown Buzzy® to be significantly faster than topical anesthetics for IV access in children while providing equivalent or better analgesia. The company’s technology has been recognized as a disruptive innovation in noninvasive pain relief with broad adoption across healthcare settings globally.[1][2][4] Their products are used in over two dozen countries with strong evidence supporting reduced opioid use post-procedure when using their devices.[1] Ongoing research includes CDC trials on reducing fainting during HPV vaccination.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pain Care Labs.